IL6 and COVID-19: The hemostatic profile of COVID-19 patients was studied by Mitrovic et al. [48], who reported the presence of a hypercoagulant state, expressed through clot formation acceleration, increased maximum clot firmness, and reduced fibrinolysis in ROTEM analysis, as the most common finding in patients with severe disease and increased levels of IL-6.